Who
Randal D. Chase
Director
Company insider
Files Form 4 as: Director, GeoVax Labs; Director, Bioject Medical Technologies.
In numbers
- Trades disclosed
- 39
- Buys
- 7
- Sells
- 0
- Bought
- $147K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 May 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,050 at $0.00 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 21 Sep 2022filed 23 Sep 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.10 | filing |
| 21 Jun 2022filed 22 Jun 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $12K10,000 at $1.21 | filing |
| 7 Dec 2021filed 8 Dec 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 11 Aug 2021filed 11 Aug 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code P | —16,613 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $83K16,613 at $5.00 | filing |
| 17 Dec 2018filed 19 Dec 2018 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —320,000 at $0.00 | filing |
| 20 Dec 2017filed 22 Dec 2017 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 13 Dec 2016filed 15 Dec 2016 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —106,700 at $0.00 | filing |
| 11 Dec 2015filed 14 Dec 2015 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 5 May 2015filed 5 May 2015 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $1,8629,800 at $0.19 | filing |
| 5 May 2015filed 5 May 2015 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $38200 at $0.19 | filing |
| 20 Apr 2015filed 20 Apr 2015 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $5,10030,000 at $0.17 | filing |
| 19 Mar 2015filed 23 Mar 2015 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,400 at $0.00 | filing |
| 5 Jun 2009filed 9 Jun 2009 | Bioject Medical Technologiesoption or derivative | SEC FORM 4 Code M | —19,000 at $0.00 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) & GeoVax Labs (NASDAQ:GOVX) Head to Head ContrastGOVX · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Randal D. Chase; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.